healthcare-thumbnail.png

Global Cough Syrup Market Research Report – Segmented By Product Type (Cough suppressants, Combinations Medications, Expectorants Antihistamines); Age Group(Paediatric, Adults); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) and Region - Size, Share, Growth Analysis | Forecast (2023 – 2030)

Cough Syrup Market Size (2023 – 2030)

The size of the world market for cough syrup was estimated at USD 4.8 billion in 2022 and is anticipated to increase to USD 6.42 billion by 2030, at a CAGR of 3.7% over the forecast period (2023-2030).

COUGH SYRUP

Major pharmaceutical firms are actively investing in research and development to provide novel cough syrup formulations that offer excellent relief and other health benefits since the global cough syrup market is currently witnessing strong expansion. Additionally, the steadily growing industry is being aided by consumers' growing knowledge of the significance of swiftly treating cough-related diseases. To obtain a competitive edge, the market participants are implementing strategic alliances, product launches, and aggressive marketing tactics.

Additionally, the availability of online platforms for buying cough syrups is accelerating market expansion and enabling customers to easily acquire a variety of products from the comfort of their homes. Geographically, all areas are experiencing strong market traction, with emerging nations exhibiting tremendous potential for growth as a result of expanding disposable incomes and bettering healthcare facilities. The dynamics of the market are also being influenced by the rising demand for goods with fewer side effects, which is driving the popularity of herbal and natural cough syrup substitutes. Despite obstacles including strict regulations and worries about cough syrup usage, the global market continues to show great prospects and is anticipated to continue growing shortly.

Key Market Insights:

According to a report in the New York Times, over 60% of parents give their kids cough medicines to assist ease the discomfort of a cold or the flu.

According to a cross-sectional time series analysis the number of pharmaceutical units purchased globally in March 2020 grew by 15% compared to the previous year's medication purchase data from 68 countries.

The pandemic is clearly to blame for the e-pharmacy market's increased acceleration, which has made pharmacy e-commerce essential to healthcare provisions (International Pharmaceutical Federation, 2021). This is because both business and healthcare have moved to the digital environment.

According to (WHO, 2004) The usage of herbal remedies and phytonutrients, often known as nutraceuticals, is continuing to grow fast throughout the world, with up to four billion people (approximately 80% of the world's population) who live in underdeveloped countries depend on herbal medicines as their main source of healthcare and conventional medicine.

Cough Syrup Market Drivers:

The frequency of respiratory diseases is boosting the demand thereby augmenting the market size of cough syrups.

As a result of numerous environmental variables, respiratory disorders are becoming more common. The growing prevalence of respiratory illnesses and allergies is substantially influenced by air pollution levels in metropolitan areas, exposure to allergens in the environment, and shifting weather patterns. These elements have increased the number of potential customers looking for cough syrups that work well to relieve symptoms and pain. The market is also affected by seasonal fluctuations in respiratory illnesses like the flu and colds. Cough syrup demand tends to peak during flu seasons and times of high allergen exposure.

Consumer education is fueling the demand for the cough syrup market.

The demand for over-the-counter cough medicines has been fueled by rising consumer knowledge of health and wellness. Nowadays, consumers are more likely to self-medicate and look for practical treatments for everyday illnesses like colds and coughs. Additionally, consumers are becoming more picky shoppers, looking for cough syrups with a great safety record and demonstrated efficacy. To make better decisions, they had to depend on medical professional’s advice and online reviews.

Formulation innovation for enhanced cough syrup options is boosting the market growth.

Multifunctional Formulations: To suit consumer demand, manufacturers are constantly coming up with new products. New formulations offer additional health advantages in addition to symptom relief. Improved flavor profiles to improve the overall customer experience and immune system support with the addition of vitamins or herbal extracts are a couple of these.

Options that are Natural and Herbal: Due to consumer preferences for goods with fewer Synthetic Ingredients and Potential Side Effects, Natural and Herbal Cough Syrups are becoming more and more popular. Due to this tendency, herbal cough syrups that incorporate conventional treatments have been created.

Revolutionizing access to cough syrup through e-commerce is augmenting the market growth.

Growth of e-commerce: The emergence of internet retail outlets has changed how people buy cough medicines. Convenience and a large product range are provided by e-commerce platforms. Cough syrups can now be ordered online and delivered right to customers' homes, allowing them to compare prices, read reviews, and take advantage of other consumer conveniences.

Accessibility: Cough syrups are now more easily available to a wider audience thanks to online retail channels, including people who live in rural or isolated areas and may not have easy access to traditional pharmacies.

Child-focused cough syrup formulations capture the pediatric market pushing the overall market growth.

Formulations for Children: The pediatric segment of the cough syrup market is gaining ground. Designed with kid-friendly flavors and dosages, pediatric cough syrups are becoming more and more popular among parents. These medications are made to be safe and tasty while effectively treating children's colds and coughs.

Parents give the safety and effectiveness of cough medicines as their kid's top priority. These goods appeal to parents looking for safe treatments for their kids because of their kid-friendly packaging, flavors, and dosages.

Cough Syrup Market Challenges and Restraints:

The rising popularity of natural and herbal cough syrups poses a challenge, for the cough syrup industry. Consumers are increasingly drawn to these products for reasons, such as their preference for remedies concerns about the safety and side effects of conventional medicine, and a desire to avoid chemical-based solutions.

Manufacturers of cough syrup now face obstacles as the demand, for herbal alternatives continues to grow. One primary issue is that producing these types of syrups may be more complicated and expensive compared to cough syrups. This is because the quality and potency of herbal ingredients can vary, requiring processing methods and manufacturing procedures.

Cough Syrup Market Opportunities.

Cough syrup companies are encountering challenges as the demand, for natural and herbal cough syrups increases. Firstly manufacturing natural and herbal cough syrups might be more complex and expensive compared to cough syrup solutions. This is because the quality and potency of herbal ingredients can vary, requiring processing and manufacturing methods.

COUGH SYRUP MARKET REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2022 - 2030

Base Year

2022

Forecast Period

2023 - 2030

CAGR

3.7%

Segments Covered

By Product Type, Age Group, Distribution Channel,  and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regional Scope

North America, Europe, APAC, Latin America, Middle East & Africa

Key Companies Profiled

Johnson and Johnson Services, Inc, Merck & Co. Inc, Pfizer Inc, Zarbee's Natural, GlaxoSmithKline PLC, Procter and Gamble, Novartis AG, Reckitt Benckiser Group PLC, Acella Pharmaceuticals LLC, Abbott Laboratories

Cough Syrup Market Segmentation: By Product Type

  • Cough suppressants

  • Combinations Medications

  • Expectorants

  • Antihistamines

In 2022, based on market segmentation by product type, Cough suppressants have the highest market revenue share 54%, owing to their fast alleviation from cough symptoms and availability over-the-counter. Because they provide a more complete approach to cough therapy. The category of combination medications is the one that is expanding the fastest in the global market for cough syrup. These cough syrups include expectorants, cough suppressants, antihistamines, and other active components in a single formulation to provide a multi-pronged approach to treating cough and cold symptoms. Combination cough syrups are becoming more and more well-liked among consumers looking for efficient and practical treatments to manage the numerous symptoms of respiratory disorders since they meet the demand for comprehensive solutions. This market area is expanding quickly because of the simplicity of using one medicine to treat several ailments.

Cough Syrup Market Segmentation: By Age Group

  • Adults

  • Paediatric

In 2022, based on market segmentation by age group, with a huge population of adults 65% suffering from various respiratory disorders, including as colds, the flu, and chronic respiratory conditions, there is a significant demand for cough syrups suited to their particular needs. The adult sector now maintains the leading position in the worldwide cough syrup market. Additionally. Adults frequently prioritize self-medication, which encourages cough syrup use in this age range.

The market's pediatric category is the one that is expanding the fastest. The demand for pediatric cough syrups is increasing as parents and other carers become more aware of the need for prompt and efficient management of children's cough and cold symptoms. To meet the needs of this market, manufacturers are increasingly concentrating on creating child-friendly formulations with palatable flavors and appropriate dosages. Additionally, expanding healthcare facilities and greater accessibility are making it easier to diagnose and treat children's respiratory conditions, which is fueling the explosive expansion of pediatric cough syrups.

Cough Syrup Market Segmentation: By Distribution Channel

  • Retail Pharmacies

  • Hospital Pharmacies

  • Online Pharmacies

In 2022, based on market segmentation by distribution channels, Retail Pharmacies have a 69% market share that accounts for more than two-thirds of the global cough syrup market revenue. Because common ailments like the common cold, the flu, or a cough are fairly basic, people frequently decide to visit a doctor unless the condition is extremely severe and persistent, and the retail pharmacy segment dominates the market. The majority of people use over-the-counter cough syrups because they don't need prescriptions. As a result, the retail stores profit greatly from this market. Furthermore, it is projected that the online pharmacy sector will have good growth as a result of the population's increased awareness of the issue.

 

Cough Syrup Market Segmentation: Regional Analysis:

  • North America

  • Europe

  • Asia-Pacific

  • South America

  • Middle East & Africa

In 2022, based on market segmentation by region, Due to the existence of numerous large key market players, the North American cough syrup market dominates the industry by 32% of the market share globally. One of the factors driving the expansion of the cough syrup industry in North America is the rising number of respiratory illnesses and the accessibility of treatments for chronic illnesses. The Asia-Pacific region is been expected to have the fastest growth over the next few years.

COVID-19 Impact Analysis on the Cough Syrup Market:

During the COVID-19 outbreak, the global cough syrup industry experienced transformations. On one hand, the pandemic brought about challenges such, as disruptions in supply chain shifts in customer behavior, and the decline of retail outlets. On the other hand, it also presented opportunities like a higher demand for cough syrups that boost immunity a surge in the popularity of e-commerce and home delivery options, and an increasing trend towards telemedicine.

Moving forward cough syrup formulations that prioritize enhancement and natural therapies are anticipated to gain prominence. Manufacturers can mitigate risks by enhancing supply chain resilience through diversification and local sourcing. Additionally establishing a presence providing convenient online purchasing options and collaborating with healthcare professionals to educate consumers will be crucial factors for success, in the post-pandemic era.

Overall the COVID-19 pandemic has deeply influenced the cough syrup market. Companies that can adapt to these changes and effectively meet consumer needs in this landscape will be well-positioned for success.

Latest Trends/ Developments:

The growing occurrence of tract infection (URTI) and other respiratory conditions worldwide is a significant driver, for market expansion. Additionally, the increasing number of more vulnerable individuals to such illnesses is contributing to the market growth. Cough syrup is mainly used to treat cough caused by prolonged exposure, to air quality, tobacco, indoor smoke, and air pollution. In addition to this, the increasing awareness of health among people and the easy availability of cough syrup in pharmacies and general stores are also contributing to the market growth. Moreover, various advancements in product development, such as the creation of cough syrups with side effects are playing a role in driving growth. Manufacturers are now focusing on producing variants that contain herbs and ingredients known for their immune-boosting properties. Furthermore, factors, like consumers increasing spending capacity and the significant growth of the pharmaceutical industry are expected to propel market growth.

Key Players:

  1. Johnson and Johnson Services, Inc

  2. Merck & Co. Inc

  3. Pfizer Inc

  4. Zarbee's Natural

  5. GlaxoSmithKline PLC

  6. Procter and Gamble

  7. Novartis AG

  8. Reckitt Benckiser Group PLC

  9. Acella Pharmaceuticals LLC

  10. Abbott Laboratories

Chapter 1. Cough Syrup Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Cough Syrup Market – Executive Summary
2.1    Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
                  2.2.1    Demand Side
                  2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Cough Syrup Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis 
Chapter 4. Cough Syrup Market - Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
                  4.5.1    Bargaining Power of Suppliers
                  4.5.2    Bargaining Powers of Customers
                  4.5.3    Threat of New Entrants
                  4.5.4    Rivalry among Existing Players
                  4.5.5    Threat of Substitutes 
Chapter 5. Cough Syrup Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Cough Syrup Market – By Product Type
6.1    Introduction/Key Findings   
6.2    Cough suppressants
6.3    Combinations Medications
6.4    Expectorants 
6.5    Antihistamines
6.6    Y-O-Y Growth trend Analysis By Product Type
6.7    Absolute $ Opportunity Analysis By Product Type, 2023-2030
Chapter 7. Cough Syrup Market – By Age Group
7.1    Introduction/Key Findings   
7.2    Adults 
7.3    Paediatric
7.4    Y-O-Y Growth  trend Analysis By Age Group
7.5    Absolute $ Opportunity Analysis By Age Group, 2023-2030 
Chapter 8. Cough Syrup Market – By Distribution Channel
8.1    Introduction/Key Findings   
8.2    Retail Pharmacies
8.3    Hospital Pharmacies
8.4    Online Pharmacies
8.5    Y-O-Y Growth trend Analysis By Distribution Channel
8.6    Absolute $ Opportunity Analysis By Distribution Channel, 2023-2030
Chapter 9. Cough Syrup Market , By Geography – Market Size, Forecast, Trends & Insights
9.1    North America
                  9.1.1    By Country
                                    9.1.1.1    U.S.A.
                                    9.1.1.2    Canada
                                    9.1.1.3    Mexico
                  9.1.2    By Product Type
                  9.1.3    By Age Group
                  9.1.4     By Distribution Channel
                  9.1.5    Countries & Segments - Market Attractiveness Analysis
9.2    Europe
                  9.2.1    By Country
                                    9.2.1.1    U.K
                                    9.2.1.2    Germany
                                    9.2.1.3    France
                                    9.2.1.4    Italy
                                    9.2.1.5    Spain
                                    9.2.1.6    Rest of Europe
                  9.2.2    By Product Type
                  9.2.3    By Age Group
                  9.2.4      By Distribution Channel
                  9.2.5    Countries & Segments - Market Attractiveness Analysis
9.3    Asia Pacific
                  9.3.1    By Country
                                    9.3.1.1    China
                                    9.3.1.2    Japan
                                    9.3.1.3    South Korea
                                    9.3.1.4    India      
                                    9.3.1.5    Australia & New Zealand
                                    9.3.1.6    Rest of Asia-Pacific
                  9.3.2    By Product Type
                  9.3.3    By Age Group
                  9.3.4      By Distribution Channel
                  9.3.5    Countries & Segments - Market Attractiveness Analysis
9.4    South America
                  9.4.1    By Country
                                    9.4.1.1    Brazil
                                    9.4.1.2    Argentina
                                    9.4.1.3    Colombia
                                    9.4.1.4    Chile
                                    9.4.1.5    Rest of South America
                  9.4.2    By Product Type
                  9.4.3    By Age Group
                  9.4.4      By Distribution Channel
                  9.4.5    Countries & Segments - Market Attractiveness Analysis
9.5    Middle East & Africa
                  9.5.1    By Country
                                    9.5.1.1    United Arab Emirates (UAE)
                                    9.5.1.2    Saudi Arabia
                                    9.5.1.3    Qatar
                                    9.5.1.4    Israel
                                    9.5.1.5    South Africa
                                    9.5.1.6    Nigeria
                                    9.5.1.7    Kenya
                                    9.5.1.8    Egypt
                                    9.5.1.9    Rest of MEA
                  9.5.2    By Product Type
                  9.5.3    By Age Group
                  9.5.4      By Distribution Channel
                  9.5.5    Countries & Segments - Market Attractiveness Analysis 
Chapter 10. Cough Syrup Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1    Johnson and Johnson Services, Inc
10.2    Merck & Co. Inc
10.3    Pfizer Inc
10.4    Zarbee's Natural
10.5    GlaxoSmithKline PLC
10.6    Procter and Gamble
10.7    Novartis AG
10.8    Reckitt Benckiser Group PLC
10.9    Acella Pharmaceuticals LLC
10.10    Abbott Laboratories

Download Sample

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Frequently Asked Questions

The size of the world market for cough syrup was estimated at USD 4.8 billion in 2022 and is anticipated to increase to USD 6.42 billion by 2030, at a CAGR of 3.7% over the forecast period (2023-2030).

 The frequency of respiratory diseases is boosting the demand thereby augmenting the market size of cough syrups, Consumer education is fueling the demand for the cough syrup market.

Based on Age Group, the segments under the Global Cough Syrup Market Include Pediatric and Adult"

The North American region is the most dominant market for cough syrup.

Johnson and Johnson Services, Merck & Co. Inc., and Pfizer Inc. are some of the key players in the global cough syrup market.

Analyst Support

Every order comes with Analyst Support.

Customization

We offer customization to cater your needs to fullest.

Verified Analysis

We value integrity, quality and authenticity the most.